| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |